Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer. 2022

Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, the Netherlands; GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center, the Netherlands; Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, the Netherlands.

Patients who receive chemoradiotherapy or bioradiotherapy (CRT/BRT) for locally advanced head and neck squamous cell carcinoma (LAHNSCC) often experience high toxicity rates interfering with oral intake, causing tube feeding (TF) dependency. International guidelines recommend gastrostomy insertion when the expected use of TF exceeds 4 weeks. We aimed to develop and externally validate a prediction model to identify patients who need TF ≥ 4 weeks and would benefit from prophylactic gastrostomy insertion. A retrospective multicenter cohort study was performed in four tertiary head and neck cancer centers in the Netherlands. The prediction model was developed using data from University Medical Center Utrecht and the Netherlands Cancer Institute and externally validated using data from Maastricht University Medical Center and Radboud University Medical Center. The primary endpoint was TF dependency ≥4 weeks initiated during CRT/BRT or within 30 days after CRT/BRT completion. Potential predictors were extracted from electronic health records and radiotherapy dose-volume parameters were calculated. The developmental and validation cohort included 409 and 334 patients respectively. Multivariable analysis showed predictive value for pretreatment weight change, texture modified diet at baseline, ECOG performance status, tumor site, N classification, mean radiation dose to the contralateral parotid gland and oral cavity. The area under the receiver operating characteristics curve for this model was 0.73 and after external validation 0.62. Positive and negative predictive value for a risk of 90% or higher for TF dependency ≥4 weeks were 81.8% and 42.3% respectively. We developed and externally validated a prediction model to estimate TF-dependency ≥4 weeks in LAHNSCC patients treated with CRT/BRT. This model can be used to guide personalized decision-making on prophylactic gastrostomy insertion in clinical practice.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D004750 Enteral Nutrition Nutritional support given via the alimentary canal or any route connected to the gastrointestinal system (i.e., the enteral route). This includes oral feeding, sip feeding, and tube feeding using nasogastric, gastrostomy, and jejunostomy tubes. Enteral Feeding,Force Feeding,Nutrition, Enteral,Tube Feeding,Gastric Feeding Tubes,Feeding Tube, Gastric,Feeding Tubes, Gastric,Feeding, Enteral,Feeding, Force,Feeding, Tube,Feedings, Force,Force Feedings,Gastric Feeding Tube,Tube, Gastric Feeding,Tubes, Gastric Feeding
D005260 Female Females
D005774 Gastrostomy Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression. Gastrostomies
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
January 2019, Oral oncology,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
November 2019, Head & neck,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
September 2024, Head & neck,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
January 2014, PloS one,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
April 2018, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
November 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
October 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
August 2022, JPEN. Journal of parenteral and enteral nutrition,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
May 2023, Cancers,
Anna C H Willemsen, and Annemieke Kok, and Laura W J Baijens, and Jan Paul de Boer, and Remco de Bree, and Lot A Devriese, and Chantal M L Driessen, and Carla M L van Herpen, and Frank J P Hoebers, and Johannes H A M Kaanders, and Rebecca T Karsten, and Sander M J van Kuijk, and Roy I Lalisang, and Arash Navran, and Susanne R Pereboom, and Annemie M W J Schols, and Chris H J Terhaard, and Ann Hoeben
February 2015, Japanese journal of clinical oncology,
Copied contents to your clipboard!